Phase 1 trial of high-dose intravenous vitamin C treatment for patients with cancer. 2007

Christopher M Stephenson, and Robert D Levin, and Christopher G Lis

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001205 Ascorbic Acid A six carbon compound related to glucose. It is found naturally in citrus fruits and many vegetables. Ascorbic acid is an essential nutrient in human diets, and necessary to maintain connective tissue and bone. Its biologically active form, vitamin C, functions as a reducing agent and coenzyme in several metabolic pathways. Vitamin C is considered an antioxidant. Vitamin C,Ascorbic Acid, Monosodium Salt,Ferrous Ascorbate,Hybrin,L-Ascorbic Acid,Magnesium Ascorbate,Magnesium Ascorbicum,Magnesium di-L-Ascorbate,Magnorbin,Sodium Ascorbate,Acid, Ascorbic,Acid, L-Ascorbic,Ascorbate, Ferrous,Ascorbate, Magnesium,Ascorbate, Sodium,L Ascorbic Acid,Magnesium di L Ascorbate,di-L-Ascorbate, Magnesium
D017321 Clinical Trials, Phase I as Topic Works about studies performed to evaluate the safety of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques in healthy subjects and to determine the safe dosage range (if appropriate). These tests also are used to determine pharmacologic and pharmacokinetic properties (toxicity, metabolism, absorption, elimination, and preferred route of administration). They involve a small number of persons and usually last about 1 year. This concept includes phase I studies conducted both in the U.S. and in other countries. Clinical Trials, Phase I,Drug Evaluation, FDA Phase I,Evaluation Studies, FDA Phase I,Human Microdosing Trial,Phase 1 Clinical Trial,Phase I Clinical Trial,Phase I Clinical Trials,Clinical Trials, Phase 1,Drug Evaluation, FDA Phase 1,Drug Evaluation, FDA Phase I as Topic,Evaluation Studies, FDA Phase 1,Human Microdosing Trials,Microdosing Trials, Human,Phase 1 Clinical Trials,Microdosing Trial, Human,Trial, Human Microdosing,Trials, Human Microdosing

Related Publications

Christopher M Stephenson, and Robert D Levin, and Christopher G Lis
January 2015, PloS one,
Christopher M Stephenson, and Robert D Levin, and Christopher G Lis
January 2016, Journal of orthomolecular medicine : official journal of the Academy of Orthomolecular Medicine,
Christopher M Stephenson, and Robert D Levin, and Christopher G Lis
January 1991, Journal of cancer research and clinical oncology,
Christopher M Stephenson, and Robert D Levin, and Christopher G Lis
September 2012, Journal of translational medicine,
Christopher M Stephenson, and Robert D Levin, and Christopher G Lis
February 2022, Life (Basel, Switzerland),
Christopher M Stephenson, and Robert D Levin, and Christopher G Lis
January 2016, Clinical case reports and reviews,
Christopher M Stephenson, and Robert D Levin, and Christopher G Lis
May 2022, Revue medicale suisse,
Christopher M Stephenson, and Robert D Levin, and Christopher G Lis
March 2021, Cancers,
Christopher M Stephenson, and Robert D Levin, and Christopher G Lis
October 2021, Journal of experimental & clinical cancer research : CR,
Christopher M Stephenson, and Robert D Levin, and Christopher G Lis
June 2022, Pharmaceuticals (Basel, Switzerland),
Copied contents to your clipboard!